Mesa Science Associates and Bryn Pharma Announce Initial Study of a New Approach to Treating Anaphylaxis
November 14, 2019 On November 10, 2019, Mr. Michael Mesa, President and CEO of Mesa Science Associates (MSA), announced the…
November 14, 2019 On November 10, 2019, Mr. Michael Mesa, President and CEO of Mesa Science Associates (MSA), announced the…
November 13, 2019 Preclinical Study of Intranasal Epinephrine Administration in Nasal Congestion Model Demonstrated Faster Absorption of Epinephrine in Canines…
November 9, 2017 Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for…
June 14, 2017 During the week beginning Sunday 6/11/17 Michael Mesa , President of Mesa Science Associates , will represent…
April 12, 2017 Mesa Science Associates (MSA) announced today, April 12, 2017 plans to join Counter Act researchers and scientists…
November 8, 2016 Recently, Michael Mesa, MSA President and CEO, was invited by Dr. Adrianne Noe , the curator of…
November 4, 2016 Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for…
September 2, 2016 Press Release Mesa Science Associates, Inc. Receives 2016 Best of Frederick Award Frederick Award Program Honors the…
August 26, 2016 Last fall, I started as an intern for the pharmaceutical development consulting firm Mesa Science Associates (MSA)…
July 26, 2016 The Science Advisory Board invites Dr. Ken Dretchen to join a global community of scientific professionals to collaborate on…
Mesa Science Associates is pleased to announce that Peyton Coady, a former intern at MSA will be graduating from James…
August 31, 2020 – Our surviving the Covid-19 experience has been an example of what having a great team can…
Frederick, MD July 17, 2020 – MSA has decided to delay the full-time return to our Frederick offices indefinitely. Unfortunately,…